South Wales, Sept. 17 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "Break Free" on Sept. 2. The details about the trademark application no. UK00004258239 published in the journal no. 2025/037 (Sept. 12).
Pencil Biosciences Ltd filed the trademark application for the below mentioned good(s)/service(s).
Class 1 : Biological preparations in the nature of eukaryotic cells, cell lines and bio-production
cell lines generated using gene editing and gene modifying engineering for scientific, laboratory, clinical or medical research; reagents, enzymes, plasmids and assays for scientific, genetic and medical research; molecular biology research tools, in the
nature of chemical, biological and biochemical reagents; biological preparations in the nature of separate gene editing components including nucleic acid sequences, RNA, mRNA, rRNA, gRNA, protein, DNA, nuclease, nickase, ribonucleotide protein (RNP)
for use in scientific, laboratory, clinical or medical research; biological preparations in the nature of genetically modified cells and vectors for scientific and research purposes; biological and chemical reagents including complexes of these molecules for use in research and development, in vitro or in vivo use in biotechnology, and for clinical and commercial use.
Class 5 : Therapeutic and prophylactic pharmaceutical products; pharmaceutical substances
and preparations; enzymes and enzyme preparations for medical use; vectors for the delivery of
genes to cells, all for medical purposes; genetically modified cells for medical use; vectors for the delivery of genes to cells for medical purposes; cell cultures, peptides, proteins, nucleic acids, modified nucleic acids, ribonucleotide protein, DNA, mRNA or complexes of these molecules for medical and commercial use.
Class 42 : Scientific, pharmaceutical and medical research and development in the field of gene modification, gene editing, gene correction, gene repair, gene modulation, cell therapy, cellular modification and gene therapy; genetic engineering services,
biotechnology services, advisory services relating to cell therapy and gene therapy products: consultancy and advisory services relating to the aforesaid services.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004258239
Disclaimer: Curated by HT Syndication.
